Howard University Telehealth Training Center
HUTTC Home | About | News | Current Projects | Past Projects | On-Demand Videos and Podcasts

5. Culturally Competent Care for Substance Users Diagnosed with HIV Disease

Module 3: Look Before You Leap: Background Issues to Designing Treatment Plans

Learning Objectives

  • Describe the impact of substance use on HAART adherence
  • Understand the special challenges of treatment of patentients with HIV and mental disorders

Pre-training Assessment

  1. Concerning antiretroviral adherence among substance users, which of the following statements is TRUE?
    1. A. HIV-positive substance users who are adherent to HAART have been shown to achieve treatment outcomes that are inferior to those of HIV-positive non-substance–users.
    2. B. HIV-positive substance users who are adherent to HAART have been shown to achieve treatment outcomes that are comparable to those of HIV-positive non-substance–users.
    3. C. HIV-positive substance users who are adherent to HAART have been shown to achieve treatment outcomes that are superior to those of HIV-positive non-substance–users.
    4. D. None of the above
    5.  
      1.  
  2. When co-administered with buprenorphine, which of the following boosted protease inhibitors are associated with significant increases in buprenorphine levels?

    1. A. Saquinavir/ritonavir
    2. B. Lopinavir/ritonavir
    3. C. Atazanavir/ritonavir
    4. D. Tipranavir/ritonavir
    5.  



Trouble viewing answers? See our Troubleshooting Tips!

« BACK

NEXT »